Under pathophysiological condition, FABP7 has been shown to be strongly expressed in several malignant tumors, such as glioma [13, 28], breast cancer [4], and malignant melanoma [14, 21] and the expression levels correlate with the rate of tumor proliferation, poor patient prognosis and survival. Here, FABP7 is linked to cancer.